Call Us Today:

Sentinel Lymph Node Biopsy

Home > Treatment > Surgical Treatment > Sentinel Lymph Node Biopsy


About Sentinel Lymph Node Biopsy

Sentinel Lymph Node Biopsy (SLNB) is a surgical procedure used to determine the extent of involvement or stage of certain types of cancers such as melanoma, breast cancer, squamous cell carcinoma, and basosquamous cell carcinoma. The test determines if cancerous cells have metastasized from the original, primary tumor site into the lymph nodes. Thus, SLNB determines the prognosis and guides the treatment.


The lymphatic system carries lymphatic fluid to the central chest, and is interrupted by multiple filters along the way - the lymph nodes. The lymphatic system provides a pathway for cancer cells to travel and spread. The first node to receive lymphatic drainage from a tumor is called the sentinel lymph node. Cancer cells may appear in the sentinel node before spreading to other lymph nodes.


SLNB is done prior to removal of the main tumor. It is a two step process which involves first identifying the sentinel lymph node followed by its removal and microscopic evaluation. The process begins at a Nuclear Medicine department of a radiology facility. The radiologist injects a harmless radioactive substance near the tumor. After 15 – 60 minutes, the area is scanned with radiation detectors to show where the substance has traveled within the lymphatic system. The images of this are then taken by the patient to their scheduled biopsy at a surgical facility.


In the operating room, the surgeon will use the Nuclear Medicine images as well as a special radiation-detecting probe (Gamma probe) to identify the greatest concentration of the radioactive tracer. Like cancer cells, the radioactive tracer will get temporarily trapped in a lymph node - a filter of the lymphatic system. The first lymph node to show the radioactive tracer is the sentinel lymph node. Frequently, the surgeon also injects a dye called methylene blue into the tumor prior to surgery. 15-30 minutes later, when the lymph node is being identified with the gamma probe, the dye can be seen staining the sentinel lymph node. This helps confirm that this is indeed the first lymphatic filter for the cancer.


Once the the surgeon identifies the lymph node, it is removed. The lymph node is sent to a pathologist for specialized testing to identify cancer cells. Identification of cancer cells within the sentinel lymph node results in more aggressive treatment such as radiation therapy, extensive lymph node removal, or even chemotherapy.

Related Articles

Melanoma within recurrent MIS
Resection margins of melanoma in situ. Reconstruction of the cheek portion of the defect with a nasolabial fold island advancement flap, reconstruction of the nasal alar component with a skin graft. Recurrent invasive melanoma 6 years later. HISTORY   73-year-old woman presents with 1-year history of recurrent pigmented lesion of the right nasal ala  found to be…
Read More
Scalp SCC Metastasis to Neck
HISTORY   64-year-old man presents in 11/2017 with tender, right postauricular swelling. Fine needle aspiration biopsy showed squamous cell carcinoma. Extensive squamous cell carcinoma of scalp was treated with 4 levels of Mohs earlier that year in 01/2017. Additional smaller squamous cell carcinoma of the same area of the scalp was treated with Mohs in…
Read More
  HISTORY 70-year-old woman presents with metastatic melanoma in the right parotid gland region of 1 year duration. Diagnosis was made with a core needle biopsy on 09-08-17. Patient also has small palpable right cervical lymph nodes with SUV 1.6 and 2.0. Patient history of melanoma began in 2001 as a pink macule of the…
Read More
HISTORY 79 year old woman presented with a 3 month history of right angle of jaw mass hardening over time. A biopsy of a separate lesion of the right central cheek on 2/21/17 showed papillated Bowen’s Disease. The jaw mass was biopsied on 2/24/17 and revealed invasive Bowen’s carcinoma – squamous cell carcinoma. DISCUSSION This…
Read More
Is there a Role for Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma?
Sentinel lymph nodes are defined as the first lymph nodes that receive metastases from a primary tumor. The concept of a first echelon node was first described by Seaman and Powers and later given the name “sentinel node” by Gould in 1960. Cabanas established the basis of modern sentinel lymph node theory by advocating that…
Read More
Ambiguous melanocytic lesions – those with histopathologic findings without a diagnostic consensus – are divided into thin and thick tumors. Thin lesions appear as dysplastic nevi and have a potential of being part of melanoma in situ or superficial spreading melanoma. We have explored diagnostic and therapeutic considerations of the thin lesions in a previous…
Read More


Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.



© 2018 SCARS Management Services. All rights reserved.